A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : FEIBA

Search Conditions:
Search Keyword : FEIBA
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: FEIBA
Appearance Frequency: 62 time(s)
Long forms: 10

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
factor eight inhibitor bypassing activity
(46 times)
Hematology
(22 times)
rFVIIa (7 times)
FVIII (3 times)
PCC (3 times)
1978 [Thrombin formation in factor IX concentrates and FEIBA (factor eight inhibitor bypassing activity) (proceedings)].
Factor Eight Inhibitor Bypassing Activity, Anti-Inhibitor Coagulant Complex, Vapor Heated
(6 times)
Hematology
(6 times)
aPCCs (2 times)
aPCC (1 time)
DIC (1 time)
2006 Surgery in patients with hemophilia and inhibitors: a review of the Norwegian experience with FEIBA.
factor eight bypassing activity
(2 times)
Hematology
(2 times)
ITI (1 time)
rFVIII (1 time)
SHA (1 time)
1997 Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity.
factor VIIa and activated prothrombin complex concentrate
(2 times)
Medicine
(1 time)
APTT (1 time)
BU (1 time)
FVIII (1 time)
1997 [Acquired haemophilia A].
4-factor prothrombin complex concentrate
(1 time)
Emergency Medicine
(1 time)
INR (1 time)
PCC (1 time)
2013 Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding.
factor VIII which is substituted by pro-coagulation factors
(1 time)
Medicine
(1 time)
--- 1977 [Radioimmunoassay of fibrinopeptide A: double antibody method].
Factor X zymogen evidences factor VIII inhibitor bypassing activity
(1 time)
Vascular Diseases
(1 time)
PCC (1 time)
1984 Apparent intrinsic prothrombinase activity of human Factor X zymogen: identification with Factor VIII inhibitor bypassing activity (FEIBA).
Factor X zymogen: identification with Factor VIII inhibitor bypassing activity
(1 time)
Vascular Diseases
(1 time)
PCC (1 time)
1984 Apparent intrinsic prothrombinase activity of human Factor X zymogen: identification with Factor VIII inhibitor bypassing activity (FEIBA).
factor XII-XI successfully treated with 'activated' prothrombin complex concentrate
(1 time)
Hematology
(1 time)
--- 1982 Life-threatening bleeding due to an acquired inhibitor to factor XII-XI successfully treated with 'activated' prothrombin complex concentrate (FEIBA)
10  fibrinogen, activated prothrombin complex concentrate
(1 time)
Hematology
(1 time)
CT (1 time)
LOT (1 time)
MCF (1 time)
2015 Rotation thromboelastometry analysis of clot formation and fibrinolysis in severe thrombocytopenia: effect of fibrinogen, activated prothrombin complex concentrate, and thrombin- activatable fibrinolysis inhibitor.